Skip to main content
. 2020 Oct 7;9(4):1041–1053. doi: 10.1007/s40123-020-00307-0

Table 2.

Adverse events reported in > 1 patient charts

All patients (N = 65)
n (%) Events
Patients with ≥ 1 AEsa 33 (50.8) 70
Specific AEs
 Blurred vision 10 (15.4) 12
 Dryness 8 (12.3) 11
 Irritation 5 (7.7) 6
 Itching 5 (7.7) 6
 Light sensitivity 5 (7.7) 5
 Burning 4 (6.2) 4
 Eye pain 3 (4.6) 4
 Tearing 3 (4.6) 3
 Change in vision 2 (3.1) 2
 Keratitis 2 (3.1) 3
 Macular degeneration 2 (3.1) 3

AE reports are limited to those recorded in the charts

AE adverse event

aAE reports in eyes not treated with LBN were not counted